Xylem Balance Sheet Health
Financial Health criteria checks 6/6
Xylem has a total shareholder equity of $10.2B and total debt of $2.3B, which brings its debt-to-equity ratio to 22.4%. Its total assets and total liabilities are $16.1B and $5.9B respectively. Xylem's EBIT is $852.0M making its interest coverage ratio 40.6. It has cash and short-term investments of $1.0B.
Key information
22.4%
Debt to equity ratio
US$2.28b
Debt
Interest coverage ratio | 40.6x |
Cash | US$1.02b |
Equity | US$10.18b |
Total liabilities | US$5.94b |
Total assets | US$16.11b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0M29's short term assets ($3.9B) exceed its short term liabilities ($2.2B).
Long Term Liabilities: 0M29's short term assets ($3.9B) exceed its long term liabilities ($3.7B).
Debt to Equity History and Analysis
Debt Level: 0M29's net debt to equity ratio (12.4%) is considered satisfactory.
Reducing Debt: 0M29's debt to equity ratio has reduced from 83% to 22.4% over the past 5 years.
Debt Coverage: 0M29's debt is well covered by operating cash flow (36.6%).
Interest Coverage: 0M29's interest payments on its debt are well covered by EBIT (40.6x coverage).